Factory Price L-Hydroxyproline CAS NO (51-35-4) Available For Sale

L-Hydroxyproline, with the chemical formula C5H9NO3 and CAS number 51-35-4, is a crucial amino acid derivative renowned for its structural significance in collagen, the most abundant protein in mammals and a fundamental component of connective tissues, bones, skin, and cartilage.

Structurally, L-Hydroxyproline is characterized by its unique hydroxyl group attached to the pyrrolidine ring of proline, distinguishing it from the standard amino acids. This hydroxylation imparts distinctive properties to collagen, enhancing its stability and strength through the formation of intermolecular hydrogen bonds, crucial for maintaining the structural integrity of various tissues.

The biosynthesis of L-Hydroxyproline primarily occurs through the post-translational modification of proline residues within collagen precursor molecules. This enzymatic hydroxylation process is catalyzed by the enzyme prolyl hydroxylase, which utilizes molecular oxygen and alpha-ketoglutarate as co-substrates, generating carbon dioxide and succinate as byproducts.

L-Hydroxyproline's incorporation into collagen fibers is pivotal for their stability and functionality. By forming cross-links between adjacent collagen molecules, L-Hydroxyproline contributes to the structural framework of tissues, conferring tensile strength and resilience against mechanical stress. Moreover, L-Hydroxyproline-rich regions within collagen molecules facilitate interactions with other extracellular matrix components, facilitating tissue remodeling and wound healing processes.

Dietary sources of L-Hydroxyproline are limited, as it is predominantly synthesized endogenously in mammals. However, consumption of collagen-rich foods such as bone broth and gelatin can provide a supplemental source of hydroxyproline, supporting collagen synthesis and tissue repair processes.

Deficiencies in L-Hydroxyproline or impaired collagen synthesis can lead to various connective tissue disorders, including scurvy, Ehlers-Danlos syndrome, and osteogenesis imperfecta, characterized by weakened bones, skin fragility, and joint hypermobility.

Conversely, therapeutic interventions aimed at enhancing L-Hydroxyproline synthesis or collagen deposition hold promise for mitigating the effects of connective tissue disorders and promoting tissue regeneration. Strategies such as dietary supplementation with vitamin C, a cofactor for prolyl hydroxylase activity, or administration of proline analogs may enhance collagen synthesis and tissue repair processes.

In conclusion, L-Hydroxyproline stands as a cornerstone in the structural integrity of collagen and connective tissues, playing a pivotal role in maintaining tissue strength, resilience, and functionality. Understanding its biosynthesis, incorporation into collagen fibers, and implications for human health is essential for advancing therapeutic approaches for connective tissue disorders and promoting overall tissue health and resilience.